NCBI PubMed Central
open access
Immune-tumor cell ligand-receptor axes driving metabolic reprogramming and therapeutic resistance in cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Melatonin overcomes ABCB1- mediated cancer multidrug resistance by modulating mitochondrial activity#345554
- Cancer signaling networks in tumor progression and drug resistance: Crosstalk, adaptive reprogramming and therapeutic targeting (Review).#209441
- CACUL1 promotes hepatocellular carcinoma progression through enhanced tumor cell proliferation and macrophage-mediated immune suppression.#418422
- Extracellular matrix protein signaling promotes multi-step cancer vasculogenic mimicry formation#263634
- Functional deficiency of circadian regulator PER2 enhances breast cancer susceptibility and progression with immunosuppression#1068002
Record · ID 330777
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive